Full-Time

Quality Engineer

Posted on 9/16/2025

Essity

Essity

10,001+ employees

No salary listed

Charlotte, NC, USA

In Person

Category
QA & Testing (1)
Requirements
  • 3+ years experience in quality assurance/quality management
  • Experience at medical device manufacturers (preferred), pharmaceutical or automotive companies
  • Experienced and certified (lead) auditor
  • Prefer advanced knowledge of quality system standards, laws, and regulations such as ISO 13485, ISO 14971, US-FDA QSRs, EU – MDD / MDR, GxPs
  • (Lean) Six Sigma Green or Black belt education helpful
  • Excellent communication and influencing skills
  • Ability to achieve results through problem-solving, decision making, prioritization, organization, and time management
  • Engineering or Life Science related bachelor’s degree
  • Business fluent in English (verbal and written), advanced / fluent in Spanish is a plus
Responsibilities
  • Act as role model for safety and quality
  • Collaborates with R&D, manufacturing, marketing, regulatory, and other functions on new product design, design change, and ad hoc projects
  • Perform complex inspections and set quality standards for both in-process and finished products and materials
  • Develops methods for testing, sampling, and training
  • Train and oversee the quality team in their use of control forms, procedures, and correcting quality problems
  • Advises personnel in collecting and organizing the quality and failure data to be reported throughout the manufacturing, repair, and complaint process
  • May act as internal consultant providing technical guidance on more complex projects
  • Apply quality principles, analyzes quality records, prepares reports and recommends improvement
  • Conduct inspection, verification and validation of components or materials used in development processes
  • Identify and address recurring problems either with the quality of the product or the reliability of testing procedures
  • Document quality issues and performance measures for management review
  • Perform continuous improvement projects and lead root cause analysis activities
  • Performs process/test equipment/software validations
  • Researches, purchases, qualifies and provides technical support for test equipment
  • Leads monthly quality review meetings
  • Performs statistical analysis and reporting
  • Writes, reviews, and approves quality system procedures, work instructions, and forms
  • Perform internal, corporate and supplier audits.
Desired Qualifications
  • Experience at medical device manufacturers (preferred)
  • (Lean) Six Sigma Green or Black belt education helpful
  • Advanced / fluent in Spanish is a plus

Company Size

10,001+

Company Stage

IPO

Headquarters

Sweden

Founded

1929

Simplify Jobs

Simplify's Take

What believers are saying

  • Essity's sustainability goals align with global trends in eco-friendly packaging.
  • The rise of remote work boosts demand for Essity's home hygiene products.
  • Essity's e-commerce expansion taps into emerging markets' growing consumer base.

What critics are saying

  • Private label brands increase competition in the hygiene sector.
  • Rising raw material costs threaten Essity's profit margins.
  • Labor strikes in Europe could disrupt Essity's supply chain.

What makes Essity unique

  • Essity is recognized on CDP's A List for climate leadership.
  • Essity's Cushelle Simply Soft targets cost-conscious consumers with premium quality.
  • Tork Vision Cleaning celebrates 10 years of data-driven cleaning technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Flexible Work Hours

Hybrid Work Options

Wellness Program

Company News

CSRwire
Apr 7th, 2025
Essity on CDP's Prestigious A List for Climate

Essity on CDP's prestigious A List for Climate.

Cision
Apr 2nd, 2025
Essity On Cdp’S Prestigious A List For Climate

Essity on CDP’s prestigious A List for climate

PR Newswire
Mar 27th, 2025
Essity'S 2025 Annual General Meeting

Essity today held the Annual General Meeting at Stockholm Waterfront Congress Centre, Sweden.STOCKHOLM, March 27, 2025 /PRNewswire/ -- The Meeting approved the Parent Company income statement and balance sheet and the consolidated income statement and consolidated balance sheet for 2024.The meeting resolved on a dividend for the financial year 2024 of SEK 8.25 per share. Record date for the dividend is set to Monday, March 31, 2025. The dividend is expected to be distributed by Euroclear Sweden AB on Thursday, April 3, 2025.The Meeting resolved that the remuneration to each director elected by the Annual General Meeting who is not employed by the company shall amount to SEK 960,000 and the Chairman of the Board of Directors is to receive SEK 2,880,000. Each member of the Remuneration Committee is to receive an additional remuneration of SEK 145,000, while the Chairman of the Remuneration Committee is to receive an additional remuneration of SEK 170,000. Each member of the Audit Committee is to receive an additional remuneration of SEK 350,000, while the Chairman of the Audit Committee is to receive an additional remuneration of SEK 490,000. Remuneration to the auditor is to be paid according to approved invoice.The Annual General Meeting resolved in accordance with the Board of Director's proposal on a cash-based incentive program

Stock Titan
Mar 27th, 2025
Essity's 2025 Annual General Meeting

Essity's 2025 Annual General Meeting.

Cision
Mar 27th, 2025
Essity’S 2025 Annual General Meeting

Essity today held the Annual General Meeting at Stockholm Waterfront Congress Centre, Sweden. The Meeting approved the Parent Company income statement and balance sheet and the consolidated income statement and consolidated balance sheet for 2024. The meeting resolved on a dividend for the financial year 2024 of SEK 8.25 per share. Record date for the dividend is set to Monday, March 31, 2025. The dividend is expected to be distributed by Euroclear Sweden AB on Thursday, April 3, 2025. The Meeting resolved that the remuneration to each director elected by the Annual General Meeting who

INACTIVE